Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer immunology and immunotherapy. Realizing the promise. Introduction.

Literature DB >> 25838372

Cancer immunology and immunotherapy. Realizing the promise. Introduction.

Kristen L Mueller.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 25838372 DOI： 10.1126/science.348.6230.54

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Potential of Radiofrequency Ablation in Combination with Immunotherapy in the Treatment of Hepatocellular Carcinoma.

Authors: Guangfu Li; Kevin F Staveley-O'Carroll; Eric T Kimchi
Journal: J Clin Trials Date: 2016-04-05

2. Nanotherapeutics for autoimmunity becomes mainstream.

Authors: Nick Giannoukakis; Wilson S Meng
Journal: Clin Immunol Date: 2015-07-11 Impact factor: 3.969

3. Sequential MR Image-Guided Local Immune Checkpoint Blockade Cancer Immunotherapy Using Ferumoxytol Capped Ultralarge Pore Mesoporous Silica Carriers after Standard Chemotherapy.

Authors: Bongseo Choi; Huijin Jung; Bo Yu; Hyunjun Choi; Joonseok Lee; Dong-Hyun Kim
Journal: Small Date: 2019-11-07 Impact factor: 13.281

4. MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells.

Authors: Eleftheria A Anastasopoulou; Ioannis F Voutsas; Michael Papamichail; Constantin N Baxevanis; Sonia A Perez
Journal: Oncoimmunology Date: 2016-05-02 Impact factor: 8.110

Review 10. The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients.

Authors: Xinbing Sui; Junhong Ma; Weidong Han; Xian Wang; Yong Fang; Da Li; Hongming Pan; Li Zhang
Journal: Oncotarget Date: 2015-08-14

Cancer immunology and immunotherapy. Realizing the promise. Introduction.

1. Potential of Radiofrequency Ablation in Combination with Immunotherapy in the Treatment of Hepatocellular Carcinoma.

2. Nanotherapeutics for autoimmunity becomes mainstream.

3. Sequential MR Image-Guided Local Immune Checkpoint Blockade Cancer Immunotherapy Using Ferumoxytol Capped Ultralarge Pore Mesoporous Silica Carriers after Standard Chemotherapy.

4. MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells.

Review 5. HIV-Host Interactions: Implications for Vaccine Design.

6. Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma.

7. The 150 most important questions in cancer research and clinical oncology series: questions 50-56.

8. Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor.

Review 9. Recent Progress in the Design and Medical Application of In Situ Self-Assembled Polypeptide Materials.

Review 10. The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients.